Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: A case report

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Patel, Sachin S ^a   Attard, Azizah ^a   Jacobsen, Pamela ^a   Shergill, Sukhi ^b  

^a BETHLEM ROYAL HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHOLINESTERASE INHIBITOR; CLOZAPINE; ESCITALOPRAM; RIVASTIGMINE; VALPROATE SEMISODIUM; CARBAMIC ACID DERIVATIVE; DONEPEZIL; GALANTAMINE; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; APATHY; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; FEMALE; GRANDIOSE DELUSION; HUMAN; MEDICAL DECISION MAKING; MENTAL HEALTH CARE; MINI MENTAL STATE EXAMINATION; OCCUPATIONAL THERAPY; PARANOIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSOCIAL WITHDRAWAL; PSYCHOTHERAPY; SCHIZOAFFECTIVE PSYCHOSIS; SOCIAL ISOLATION; TREATMENT OUTCOME; VISUAL HALLUCINATION; HALLUCINATION; PSYCHOLOGY; REVIEW; SCHIZOPHRENIA; COGNITION; EMBASE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; SYMPTOM; SYSTEMATIC REVIEW; DRUG RESISTANCE;

CHOLINESTERASE INHIBITORS; GALANTAMINE; HALLUCINATIONS; HUMANS; INDANS; PHENYLCARBAMATES; PIPERIDINES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; ADULT; ANTIPSYCHOTIC AGENTS; DRUG RESISTANCE; FEMALE;

EID: 77956477792     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-68     Document Type: Article

References (9)

1. Kersten D, Mamassian P, Yuille A. Object perception as bayesian inference. Annu Rev Psychology 2004, 55:271-304.
2. Friston K. A theory of cortical responses. Phil Trans R Soc B 2005, 360:815-836. 10.1098/rstb.2005.1622, 1569488, 15937014.
3. Yu D, Dayan P. Acetylcholine in cortical inference. Neural Networks 2002, 15:719-730. 10.1016/S0893-6080(02)00058-8, 12371522.
4. Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, Pasquier F, Johnson S. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24 week open-label study. Dementia and Geriatric Cognitive Disorders 2007, 23(6):401-5. 10.1159/000101512, 17409748.
5. Fabbrini G, Barbanti P, Aurilia C, Pauletti C, Lenzi GL, Meco G. Donepezil in the treatment of hallucinations and delusions in Parkinson's disease. Neurological Sciences 2004, 23(1):41-43.
6. Cummings JL. Cholinesterase Inhibitors: A new Class of Psychotropic Compounds. Am J Psychiatry 2000, 157:1. 4-15.
7. Cummings JL, Askin-Edgar S. Evidence for Psychotropic Effects of Acetylcholinesterase Inhibitors. CNS Drugs 2000, 13(6):385-395.
8. Bullock R, Cameron A. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. Current Medical Research and Opinion 2002, 18(5):258-64. 10.1185/030079902125000813, 12240787.
9. Haddock G, McGarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med 1999, 29:879-889. 10.1017/S0033291799008661, 10473315.